2024: research highlights of last year and the year ahead
With the announcement of some very encouraging results from completed clinical trials last year, and a number of promising new projects focused on disease modification - the outlook for 2024 is looking good!
Learn moreUpcoming GBA1 conference in Montreal
Cure Parkinson’s is co-sponsoring a large three-day international conference on June 27th – 29th that will be focused on all aspects of GBA1 research, from basic science to clinical trials.
Time to ROCK-PD
Researchers in Germany are conducting a new phase 2 clinical trial to determine if an existing cardiovascular drug called fasudil, could help people with Parkinson’s.
International Women’s Day and Parkinson’s
On 8 March, we celebrate International Women’s Day by shining a light on the work of female researchers and scientists who have made significant contributions to the Parkinson’s community, and the impact of their work in advancing our understanding of the role of sex and…
The Power of HIIT for Parkinson’s
A small pilot study has found that high-intensity interval training – or HIIT – can have positive effects for people with Parkinson’s, both on overall well-being and potentially on brain chemistry.
Latest updates in the field of neurotrophic factors in Parkinson’s
Neurotrophic factors such as GDNF are still being actively investigated as a potential treatment for Parkinson’s, and alternative methods of delivery are currently being explored.